In a thorough analysis of existing research, scientists have concluded that taking paracetamol (also known as acetaminophen) during pregnancy is not clearly associated with an increased risk of autism spectrum disorder (ASD) or attention-deficit/hyperactivity disorder (ADHD) in children. The findings offer relief for pregnant individuals and their doctors, clarifying that the available evidence does not support the idea that this widely used pain-reliever causes these neurodevelopmental conditions.
Review Examined Numerous Studies—but Quality Was Low
The review evaluated nine systematic reviews, covering 40 observational studies that explored prenatal paracetamol exposure and later diagnoses of autism, ADHD or other developmental disorders in children. However, research quality was rated from “low” to “critically low”, and many studies did not eliminate alternative explanations such as family genetics or maternal health conditions. The authors found that apparent associations disappeared when sibling-comparison studies were used—suggesting that shared factors rather than paracetamol itself may account for the findings.
Expert Guidance: Pain-Relief Use in Pregnancy
Lead authors emphasise that if a pregnant person needs paracetamol for symptoms like fever or significant pain, they should not avoid it on the basis of autism or ADHD risk alone. Indeed, untreated high fever or inflammation can pose greater danger to the developing foetus than the occasional use of this medication. Other pain-relievers, like ibuprofen, are typically not recommended during pregnancy, further supporting paracetamol as a sensible option when needed.
Implications for Pregnant People and Health Professionals
This analysis provides much-needed clarity after prior public concern that prenatal use of a common analgesic might raise long-term risk for children. Expectant parents who have taken paracetamol need not feel undue guilt, as current data do not support a causal link to autism or ADHD. Healthcare providers can continue offering informed guidance, emphasising that genetic and environmental factors remain the stronger contributors to these conditions. As always, medication use during pregnancy should be discussed with a qualified clinician.
